×

Highlighting the MS Community This Holiday Season and Always

As we approach the season of giving, the Multiple Sclerosis Association of America (MSAA) would like to bring special attention to the many wonderful community members that we serve. With our mission of Improving Lives Today, MSAA genuinely strives to … Continue reading → Source:…

MS relapses peak in spring, summer as temperatures rise: Study

Relapses in people with relapsing-remitting multiple sclerosis (MS) may be more common in spring and summer, coinciding with warmer temperatures, low humidity, and greater fluctuations in atmospheric pressure, according to a study from Poland. Stressful life events and infections were the most frequent potential relapse…

Battle of the High Efficacy Agents…Is anti-CD20 depletion the bee’s knees compared to migration inhibition?

Tweet This paper potentially hasn’t been peer-reviewed and looks at the differences between natalizumab and ocrelizumab and does a virutal head to head with the conclusion that anti-CD20 is more effective than natalizumab on disability progression and concludes that ocrelizumab is better….So is this bad…

Researchers identify enzyme as new target for MS myelin repair

An enzyme called CEMIP could be a target for small-molecule inhibitors that aim to promote myelin repair in people with multiple sclerosis (MS) and other conditions marked by myelin loss, a study found. Researchers discovered that CEMIP, which is elevated in areas of inflammatory nerve…

2025 Year in Review Through Bingo

By Stacie Prada December is the perfect time to reflect on how the past year measured up to hopes and goals. In January, I created a 2025 Bingo card that reflected various priorities I have. It proved useful and motivating … Continue reading → Source:…

Can music therapy make MS spasticity injections less painful?

A clinical trial testing whether music therapy can make botulinum toxin injections for spasticity more tolerable for people with multiple sclerosis (MS) and other neurological conditions is enrolling participants at Clermont-Ferrand University Hospital in France.  The study’s protocol was published in PLOS One, in a paper…